Phase 3 Trial to Compare Two Cagrilintide Versions and Placebo Registered
A new Phase 3 trial, NCT07745504, comparing two injectable cagrilintide versions and placebo in people with excess body weight was registered, dated Aug 4, 2026.
Read Full ArticleAll News
Exenatide Pancreatic Cancer Safety Study Remains Recruiting
A pan-European post-authorisation safety study on exenatide and pancreatic cancer risk in type 2 diabetes patients is recruiting as of August 2026.
Glucagon Featured in Metabolism Research Validation Trial (NCT06286761)
A trial involving glucagon, titled Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research, is recruiting as of Aug 4, 2026.
Glucagon-Related Trial "GLP-1 Use in Pregnancy" Now Recruiting
A new trial, "Gestational Response, Outcomes, and Weight After GLP-1 Use," began recruiting as of August 4, 2026, per ClinicalTrials.gov.
Phase 1 Trial of Gonadorelin-Related Zoladex Now Recruiting
A Phase 1 trial evaluating subcutaneous ZOLADEX 10.8 mg for ovarian suppression in HR+, HER2- advanced breast cancer began recruiting as of Aug 4, 2026.
Oxytocin-Related Trial on Digital Prenatal Education Registered
A new trial, "Digital Prenatal Education to Reduce Fear of Childbirth in Term Pregnancy," was registered on 2026-08-04 and is not yet recruiting.
Semaglutide Phase 2 Trial in Type 1 Diabetes Obesity Recruiting
A Phase 2 trial testing semaglutide, a GLP-1 analogue, for obesity complicating type 1 diabetes is now recruiting, per an update dated August 4, 2026.
Survodutide Trial NCT05202353 Now Active, Not Recruiting
A Phase 1 trial comparing survodutide (BI 456906) to semaglutide on liver glucagon receptor activity is active, not recruiting, as of Aug 4, 2026.
Survodutide Phase 1 Formulation Comparison Trial Completed
A Phase 1 trial comparing two survodutide formulations in healthy volunteers completed as of Aug 4, 2026, per ClinicalTrials.gov.
Tirzepatide Post-Bariatric Trial GRABS Now Active, Not Recruiting
Update on Aug 4, 2026: the GRABS Phase 2/3 pilot trial of tirzepatide after bariatric surgery is active but no longer recruiting participants.
Triptorelin Featured in Phase 3 Breast Cancer Trial Update (NCT05879926)
A Phase 3 trial involving triptorelin for ovarian function suppression in premenopausal breast cancer patients is recruiting as of Aug 4, 2026.
Cagrilintide Phase 3 Trial in Overweight/Obesity and Type 2 Diabetes Now Active
A Phase 3 trial of cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes is now active but not recruiting, as of Aug 3, 2026.
Gonadorelin Trial NCT07340619 Registered, Not Yet Recruiting
A new Phase 2 trial involving gonadorelin, NCT07340619, was registered on 2026-08-03 and is not yet recruiting, per ClinicalTrials.gov.
Ibutamoren (LUM-201) Phase 3 Trial in Children Recruiting
A Phase 3 study of LUM-201, related to ibutamoren, in children with growth hormone deficiency is recruiting as of August 3, 2026, per ClinicalTrials.gov.
Semaglutide Phase 4 Trial on Appetite and Eating Behavior Completed
A Phase 4 trial studying semaglutide's long-term effects on appetite and eating behavior was marked completed on Aug 3, 2026, per ClinicalTrials.gov.
Somatostatin-Related Trial NCT06991738 Registered, Not Yet Recruiting
A Phase 1/2 trial testing 177Lu-DOTA-EB-TATE in Hurthle-cell thyroid cancer patients was registered, with status listed as not yet recruiting as of Aug 3, 2026.
Thymosin Alpha-1 NSCLC Trial (NCT06139419) Marked Completed
A Phase 2 trial testing thymosin alpha-1 in locally advanced NSCLC patients undergoing chemoradiotherapy and immunotherapy consolidation is now listed as completed.
Tirzepatide Phase 3 Trial in Heart Failure Patients With Obesity Registered
A Phase 3 trial evaluating tirzepatide in reduced ejection fraction heart failure patients with obesity was registered August 3, 2026, listed as not yet recruiting.
Goserelin: Phase 3 Trial Update on Exemestane Plus Entinostat Reported
A phase 3 trial tracking goserelin, evaluating exemestane with or without entinostat in HR-positive breast cancer, is active but not recruiting as of July 31, 2026.
Tirzepatide Phase 4 Trial "Fibrosis Lessens After Metabolic Surgery" Recruiting
A Phase 4 trial involving tirzepatide, titled "Fibrosis Lessens After Metabolic Surgery," is recruiting as of July 31, 2026, per ClinicalTrials.gov.
Trial Studying Vagus Nerve Stimulation for Tirzepatide Poor Response Recruiting
A clinical trial examining transcutaneous auricular vagus nerve stimulation for poor weight-loss response to incretin receptor agonists is now recruiting, per a 2026-07-31 update.